Skip to content
2000
image of Guchang Zhixie Pill: A Comprehensive Review of the Clinical Applications, Toxicological Profile, and Quality Markers

Abstract

Objective

This study systematically reviews the clinical applications, toxicological profile, and quality markers of Guchang Zhixie Pill, offering a reference for its rational clinical use, as well as its quality and safety assessment.

Methods

Relevant literature on the historical development, clinical applications, toxicology, and molecular characteristics of Guchang Zhixie Pill was retrieved from CNKI (https://www.cnki.net/), VIP (https://www.cqvip.com/), Sci-Hub (https://sci-hub.hkvisa.net/), TCMSP (https://old.tcmsp-e.com/tcmsp.php), Google Scholar (https://scholar.google.cz/schhp?hl=zh-CN), and PubMed (https://pubmed.ncbi.nlm.nih.gov/). Quality markers were predicted and analyzed based on established criteria to provide a scientific basis for ensuring clinical safety and efficacy.

Results

Formulated based on Wumei Pill, Guchang Zhixie Pill is widely used in the treatment of ulcerative colitis and irritable bowel syndrome. Quality marker prediction and analysis, conducted in accordance with the “five principles” of quality marker identification, indicated that ursolic acid, oleanolic acid, chlorogenic acid, neochlorogenic acid, citric acid, 5-hydroxymethylfurfural, coptisine, berberine hydrochloride, (+)-magnoflorine, 6-shogaol, 10-gingerol, dehydrocostus lactone, papaverine, noscapine, palmatine, and corydaline serve as potential Q-markers for this formulation.

Conclusion

As a classical prescription for intestinal astringency and antidiarrheal therapy, ensuring its rational clinical application is essential. The identification of 16 quality markers provides a scientific reference for quality control in future research.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/ctmc/10.2174/0115680266328765250217050926
2025-03-21
2025-09-13

  • From This Site

    /content/journals/ctmc/10.2174/0115680266328765250217050926
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Zhang Z.J. Treatise on Cold Damage Diseases. Beijing, China People's Medical Publishing House 2015
    [Google Scholar]
  2. Liu X.C. Chen S.L. Xiao X.H. Zhang T.J. Hou W.B. Liao M.L. A new concept on quality marker of Chinese materia medica: Quality control for Chinese medicinal products. Chin. Tradit. Herbal Drugs 2016 47 1443 1457 10.7501/j.issn.0253‑2670.2016.09.001
    [Google Scholar]
  3. Liu C. Zhang H.Y. Li D. Reflection on clinical dosage of traditional Chinese medicine. Zhonghua Zhongyiyao Zazhi 2020 35 5508 5511
    [Google Scholar]
  4. Sun S.M. Essential Prescriptions Worth a Thousand for Emergencies. Shanxi, China Shanxi Science and Technology Publishing House 2020
    [Google Scholar]
  5. Wang X. Medical Secrets of an Official. Beijing, China China Medical Science Press 2011
    [Google Scholar]
  6. Yan Y.H. Yanshi Jisheng Fang. Beijing, China China Medical Science Press 2012
    [Google Scholar]
  7. Chen Y.Z. Treatise on the Three Categories of Pathogenic Factors and Prescriptions. Beijing, China People's Medical Publishing House 2007
    [Google Scholar]
  8. Chen S.W. Prescriptions from the Great Peace Imperial Grace Pharmacy. Beijing, China China Press of Traditional Chinese Medicine 2020
    [Google Scholar]
  9. Zhu Z.H. Danxi’s Experiential Therapy. Beijing, China People’s Military Medical Press 2007
    [Google Scholar]
  10. Xue J. Neike Zhaiyao. Beijing, China China Medical Science Press 2012
    [Google Scholar]
  11. Wu K. Yifang Kao. Beijing, China People's Medical Publishing House 2018
    [Google Scholar]
  12. Zhao X.K. Thorough Knowledge of Medicine. Beijing, China People's Medical Publishing House 2005
    [Google Scholar]
  13. Yu T. Orthodox Transmission of Medicine. Shanxi, China Shanxi Science and Technology Publishing House 2013
    [Google Scholar]
  14. You Y. Jinkui Yi. Beijing, China China Press of Traditional Chinese Medicine 1999
    [Google Scholar]
  15. Wang A. Collected Exegesis of Recipe. Beijing, China China Press of Traditional Chinese Medicine 1997
    [Google Scholar]
  16. Chen F.Z. Compendium of Pediatrics. Beijing, China People's Medical Publishing House 2006
    [Google Scholar]
  17. Chen X.Y. Shifang Miaoyong. Fujian, China Fujian Science and Technology Publishing House 2007
    [Google Scholar]
  18. Wu Q. Golden Mirror of Medicine. Beijing, China China Press of Traditional Chinese Medicine 1994
    [Google Scholar]
  19. Wang A. Bencao Beiyao. Beijing, China People's Medical Publishing House 2017
    [Google Scholar]
  20. Li S.Z. Compendium of Materia Medica. Xian, China Xian Jiaotong University Press 2015
    [Google Scholar]
  21. Wang H.G. Tangye Bencao. Beijing, China China Press of Traditional Chinese Medicine 2015
    [Google Scholar]
  22. Ling H. Bencao Haili. China Press of Traditional Chinese Medicine 1982
    [Google Scholar]
  23. Zhao J.C. Complete Record of Sacred Benevolence. Beijing, China China Press of Traditional Chinese Medicine 2018
    [Google Scholar]
  24. Zhang Z.C. Bencao Chongyuan. Beijing, China China Press of Traditional Chinese Medicine 1992
    [Google Scholar]
  25. Wang A. Bencao Yidu. Taiyuan, China Shanxi Science and Technology Publishing House 2015
    [Google Scholar]
  26. Zhu S. Puji Fang. Beijing, China People's Medical Publishing House 1982
    [Google Scholar]
  27. Chen Z.M. Compendium of Effective Prescriptions for Women. Beijing, China China Medical Science Press 2019
    [Google Scholar]
  28. Shi W. Depei Bencao. Shanghai, China Shanghai Scientific & Technical Publishers 2000
    [Google Scholar]
  29. Wang H.Y. Peaceful Holy Benevolent Prescriptions. Beijing, China People's Medical Publishing House 2005
    [Google Scholar]
  30. Qian Y. Key to Therapeutics of Children’s Diseases. Nanning, China Guangxi Science and Technology Press 2015
    [Google Scholar]
  31. Shi K. Shizai Zhifang. Shanghai, China Shanghai Scientific & Technical Publishers 2003
    [Google Scholar]
  32. Han H. Hanshi Yitong. Beijing, China China Press of Traditional Chinese Medicine 1989
    [Google Scholar]
  33. Chen J.M. Bencao Mengquan. Beijing, China China Press of Traditional Chinese Medicine 2013
    [Google Scholar]
  34. Huang G.X. Bencao Qiuzhen. Taiyuan, China Shanxi Science and Technology Publishing House 2015
    [Google Scholar]
  35. Lan M. Diannan Bencao. Beijing, China China Press of Traditional Chinese Medicine 2013
    [Google Scholar]
  36. Gong T.X. Longevity and Life Preservation. Taiyuan, China Shanxi Science and Technology Publishing House 2006
    [Google Scholar]
  37. Wei Y.L. Shiyi Dexiao Fang. Shanghai, China Second Military Medical University Press 2006
    [Google Scholar]
  38. Ni J.M. Bencao Huiyan. Shanghai, China Shanghai Scientific & Technical Publishers 2005
    [Google Scholar]
  39. Tang S.W. Zhenglei Bencao. Beijing, China China Medical Science Press 2021
    [Google Scholar]
  40. Zhang J.B. Complete Works of Jingyue. Beijing, China China Press of Traditional Chinese Medicine 1994
    [Google Scholar]
  41. Zhu G.Y. Leizheng Huoren Shu. Tianjin, China Tianjin Science and Technology Press 2003
    [Google Scholar]
  42. Su J. Newly Revised Materia Medica. Beijing, China China Medical Science Press 2019
    [Google Scholar]
  43. Chang M.Y. Rihuazi Bencao. Beijing, China China Medical Science Press 2016
    [Google Scholar]
  44. Lu D.X. Kaibao Bencao. Beijing, China Beijing Science and Technology Press 2019
    [Google Scholar]
  45. Su S. Bencao Tujing. Anhui Science and Technology Press Anhui, China. 1994
    [Google Scholar]
  46. Liu W.T. Bencao Pinghui Jingyao. Beijing, China China Press of Traditional Chinese Medicine 2013
    [Google Scholar]
  47. Luo T.Y. Weisheng Baojian. Beijing, China China Press of Traditional Chinese Medicine 2013
    [Google Scholar]
  48. Hong Z. Hongshi Yanji Fang. Shanghai, China Shanghai Scientific & Technical Publishers 2003
    [Google Scholar]
  49. Shen K. Sushen Liangfang. Beijing, China China Medical Science Press 2019
    [Google Scholar]
  50. Yang S.Y. Renzhai Zhizhi Fanglun. Guizhou, China Guizhou Science and Technology Press 2016
    [Google Scholar]
  51. Wang G. Boji Fang. Shanghai, China Shanghai Scientific & Technical Publishers 2003
    [Google Scholar]
  52. Yan Y.H. Chongding Yanshi Jisheng Fang. Beijing, China People's Medical Publishing House 1980
    [Google Scholar]
  53. Zhang B.C. Bencao Biandu. Taiyuan, China Shanxi Science and Technology Publishing House 2015
    [Google Scholar]
  54. Zhang L. Tang R.S. Song J. Zhang H.M. Fu Y.L. Textual Research on Principle of Dose Conversion in Ancient Famous Classical Formulas. Chin. J. Exp. Tradit. Med. Formula. 2024 30 10 196 202 10.13422/j.cnki.syfjx.20240668
    [Google Scholar]
  55. Lin Y.Q. Mu L.C. Li Q.W. Tong X.L. Literature analysis on the measured weights of unmeasured unit drugs. Zhonghua Zhongyiyao Zazhi 2018 33 02 740 743 https://doi.org/CNKI:SUN:BXYY.0.2018-02-093
    [Google Scholar]
  56. Jia Y. Guchang Zhixie pill for the treatment of chronic ulcerative colitis in 30 cases. J. Shaanxi Univ. Chin. Med. 2008 31 04 36 37 10.13424/j.cnki.jsctcm.2008.04.014
    [Google Scholar]
  57. Zhang W.W. Mai L.R. Zhang L. Effect of Gegen Qinlian Decoction Combined with Guchang Zhixie Pill on Ulcerative Colitis and lts Effect on Serum Levels of lL-1,IL-6 and TNF-α. Zhonghua Zhongyiyao Xuekan 2021 39 09 212 215 10.13193/j.issn.1673‑7717.2021.09.053
    [Google Scholar]
  58. Wang J.Z. Wang P. Hou K.T. Zhang Y.X. Effect of Guchang Zhixie Pill Combined with Kangfuxin Enema on Intestinal Flora and Inflammatory Factors in Patients with Ulcerative Colitis. World J. Integrated Tradit. and Western Med. 2020 15 12 2289 2293 10.13935/j.cnki.sjzx.201229
    [Google Scholar]
  59. Wu J.H. Chen Z.K. Efficacy of Guchang Zhixie Pill and Sulfasalazine in Treatment of Paients withUlcerative Colitis and Influence of lL- 2 and lL- 8 in Serum, Liaoning. J. Tradit. Chin. Med. 2014 41 03 462 464 10.13192/j.issn.1000‑1719.2014.03.031
    [Google Scholar]
  60. Lei R.X. Wu G.R. Clinical observation of Guchang Zhixie pill combined with acupoint acupuncture in the treatment of diarrheal irritable bowel syndrome. Chin. J. Trauma and Disability Med. 2013 21 10 203 204 https://kns.cnki.net/kcms2/article/abstract?v=_NV5_o307Bxp3TTJOoY5T2zV8BdxquT8_SSqduBdMhdTVR4u5nv1ttNiipCSQ24u2BqQBEhovPEKgadn5AguhfEk5LATa98ioAo11cPtviLntk4sQWWnqaVTXtDybQdMlHx81yKHdeg=&uniplatform=NZKPT&language=CHS
    [Google Scholar]
  61. Wu H. Fan Z. Ye M.Q. Clinical observation of Guchang Zhixie pill combined with Flupentixol and Melitracen Tablets in the treatment of diarrheal irritable bowel syndromeInner. Mongolia J. Tradit. Chin. Med. 2016 35 02 86 87 10.16040/j.cnki.cn15‑1101.2016.02.087
    [Google Scholar]
  62. Wu M.Y. Fang Y. Huang X.G. Zhang Z. Observation on the curative effect of OctyloniuM BroMide combined with Guchang Zhixie pill in the treatment of diarrheal irritable bowel syndrome. Chin. Primary Health Care 2011 25 9 86 87 10.3969/j.issn.1001‑568X.2011.09.048
    [Google Scholar]
  63. Guo Y. Wei X.J. Wang Y.X. Clinical effects of Guchang Zhixie Pill combined with mesalazine on mildlyactive Crohn’s disease. Zhongchengyao 2019 41 08 1844 1847 10.3969/j.issn.1001‑1528.2019.08.018
    [Google Scholar]
  64. Ren J.T. Observation on curative effect of Jiedu Huayu Decoction combined with Guchang Zhixie pill on 84 patients with active ulcerative colitis. J. Qiqihar Medical Univ. 2019 40 13 1620 1621 10.3969/j.issn.1002‑1256.2019.13.015
    [Google Scholar]
  65. Yang Y. Value of Guchang Zhixie pill combined with compound glutamine enteric-soluble capsules in the treatment of ulcerative colitis. J. North Pharm. 2018 15 03 35 36
    [Google Scholar]
  66. Wu G.H. Guo L.J. Clinical study on Guchang Zhixie Pills combined with sulfasalazine in treatment of ulcerative colitis. Drugs & Clinic. 2018 3 06 1410 1414
    [Google Scholar]
  67. Sun G.Y. Chen B.L. Treatment of diarrhea-dominated irritable bowel syndrome with Piverium bromide combined with Guchang Zhixie Pill. Guangdong Yixue 2003 12 1365 1366 10.13820/j.cnki.gdyx.2003.12.067
    [Google Scholar]
  68. Yang H.Y. Zhang C. Lei L.P. Determination of Morphine in Guchang Zhixie Pills by HPLC. China Pharmaceuticals. 2012 21 18 44 45
    [Google Scholar]
  69. Li X. Zhang M.T. Guo X.X. Wang J.D. Li D.H. Ma X. Study on Change of Morphine Content in Yingsuqiao(Papaveris Pericarpium) Before and After Processing. Liaoning J. Trad. Chin. Med. 2023 50 12 174 178 10.13192/j.issn.1000‑1719.2023.12.048
    [Google Scholar]
  70. Yang H. Yun L. Wang H. Acute liver function injury caused by papaverine hydrochloride injection: a case report. China Pharm. 2019 22 01 125 126 10.3969/j.issn.1008‑049X.2019.01.033
    [Google Scholar]
  71. Miller J.A. Cross D.T. Moran C.J. Dacey R.G. Jr McFarland J.G. Diringer M.N. Severe thrombocytopenia following intraarterial papaverine administration for the treatment of vasospasm. J. Neurosurg. 1995 83 3 435 437 10.3171/jns.1995.83.3.0435 7666219
    [Google Scholar]
  72. Kahramaner Z. Erdemir A. Türkoğlu E. Coşar H. Sütçüoğlu S. Özer E.A. Papaverine intoxication in a newborn: an unusual case report. Turk. J. Pediatr. 2014 56 5 532 534 26022590
    [Google Scholar]
  73. An J.J. First aid and nursing care of anaphylactic shock caused by papaverine. Chin. J. Convalescent Med. 2018 27 02 223 224 10.13517/j.cnki.ccm.2018.02.048
    [Google Scholar]
  74. Gao X.Y. Xia Y.M. Rare adverse reactions of papaverine. Chin. Community Doctors 2006 02 59
    [Google Scholar]
  75. Wang L.P. Literature Review of Adverse Drug Reactions Induced by Papaverine. Chinese Journal of Drug Abuse Prevention and Treatment. 2020 26 04 233 236 10.15900/j.cnki.zylf1995.2020.04.014
    [Google Scholar]
  76. Yang L.L. Xing J.P. Zhang Z.Y. Wang X. Tan J.Y. Wang X. Cheng S.Q. Wen J. Xu X.F. Li X.R Effects of Purification on Quality of Fructus Mume and the Quality Standard Research of Pulp of Fructus Mume. World Chin. Med. 2024 19 01 1-6 +13 https://xueshu.baidu.com/usercenter/paper/show?paperid=160j0t80102704n019120g90e6235581&site=xueshu_se&hitarticle=1
  77. Zhang Y. Qu Q. Lei X. Zhao X. Zhang X. Wei X. Tang Y. Duan X. Song X. Quality markers of Guchang Zhixie pills based on multicomponent qualitative and quantitative analysis combined with network pharmacology and chemometric analysis. J. Pharm. Biomed. Anal. 2024 240 115934 10.1016/j.jpba.2023.115934 38157739
    [Google Scholar]
  78. Yang Y.T. Wang R. Qian C.C. Wu R. Ou J.M. Research progress of chemical compositions, pharmaological action and quality markers prediction of Mume fructus. Zhongchengyao 2023 45 05 1583 1588 10.3969/j.issn.1001‑1528.2023.05.032
    [Google Scholar]
  79. Fu L. Fu Q. Li J. Tong X. Research progress on chemical constituents and pharmacological effects of Coptidis rhizoma. Acta Chin. Med. Pharmacol. 2021 49 02 87 92 10.19664/j.cnki.1002‑2392.210044
    [Google Scholar]
  80. Xu T. Cong Z.F. He M.Y. Dong P. Dai L. Gao P. Research Progress and Quality Marker Analysis ofZingiberis Rhizoma, Shandong J. Trad. Chin. Med. 2022 41 05 569 575 10.16295/j.cnki.0257‑358x.2022.05.021
    [Google Scholar]
  81. Zheng J.M. Shang M.Y. Wang J.L. Dai G.N. Song J.Y. Dai B.Z. Research progress on chemical constituents, pharmacological effects and clinicaapplications of Aucklandiae Radix and prediction analysis on Q-Marker. Chin. Tradit. Herbal Drugs 2021 53 22 4198 4213 10.7501/j.issn.0253‑2670.2022.13.033
    [Google Scholar]
  82. Zhang X.P. Shi X.F. Zhang H.Y. Zhu R.Y. Zhang C.X. Establishment of HPLC Fingerprint and Content Determination of 5 Components inPapaveris Pericarpium. China Pharm. 2021 32 22 2755 2760 10.6039/j.issn.1001‑0408.2021.22.12
    [Google Scholar]
  83. Feng J. Chen K. Shen S. Luo Y. Liu X. Chen X. Gao W. Tong Y. The composition, pharmacological effects, related mechanisms and drug delivery of alkaloids from Corydalis yanhusuo. Biomed. Pharmacother. 2023 167 115511 115511 10.1016/j.biopha.2023.115511 37729733
    [Google Scholar]
  84. Kim C.K. Yu J. Lee M. Molecular Networking-Guided Isolation of a Phenolic Constituent from Prunus mume Seed and Its Antioxidant and Anti-Inflammatory Activities. Foods 2023 12 6 1146 1146 10.3390/foods12061146 36981073
    [Google Scholar]
  85. Zhang J.C. Liang H. Wang Y. Xi W. Li Z.G. Research Progress of Pharmacological Action of Wumei(Mume Fructus). Liaoning Zhongyiyao Daxue Xuebao 2021 23 08 122 126 10.13194/j.issn.1673‑842x.2021.08.025
    [Google Scholar]
  86. Salama S.A. AL-Faifi Z.E. Masood M.F. El-Amier Y.A. Investigation and Biological Assessment of Rumex vesicarius L. Extract: Characterization of the Chemical Components and Antioxidant, Antimicrobial, Cytotoxic, and Anti-Dengue Vector Activity. Molecules 2022 27 10 3177 10.3390/molecules27103177 35630653
    [Google Scholar]
  87. Liu Y. Ren B.J. Zou X.Y. Lu J.Y. Wang L. Gan D.H. Research progress of pharmacological action and effective drug carrier of Berberine. J Hainan Med Uni 2020 26 17 1348-1352+1357 10.13210/j.cnki.jhmu.20200408.006
    [Google Scholar]
  88. Alipour Noghabi S. Ghamari kargar P. Bagherzade G. Beyzaei H. Comparative study of antioxidant and antimicrobial activity of berberine-derived Schiff bases, nitro-berberine and amino-berberine. Heliyon 2023 9 12 e22783 10.1016/j.heliyon.2023.e22783
    [Google Scholar]
  89. Xu Z. Zhang X. Wang W. Zhang D. Ma Y. Zhang D. Chen M. Fructus mume (Wu Mei) attenuates acetic acid-induced ulcerative colitis by regulating inflammatory cytokine, reactive oxygen species, and neuropeptide levels in model rats. J. Med. Food 2022 25 4 389 401 10.1089/jmf.2021.K.0155 35438553
    [Google Scholar]
  90. Xiang J. Liu X. Zhong S. Fang Z. Shen S. Tang J. Lai S. Lai K. Fructus mume protects against cigarette smoke induced chronic cough Guinea pig. J. Med. Food 2020 23 2 191 197 10.1089/jmf.2019.4423 32017647
    [Google Scholar]
  91. Fan A.Q. Hou B.L. Zhu J. Metabolomics-based study on the mechanism of treatment of ulcerative colitis by the traditional Chinese medicine Guchang Zhixie Wan in mice. Zhongguo Xin Yao Zazhi 2024 33 11 1144 1154 10.3969/j.issn.1003‑3734.2024.11.013
    [Google Scholar]
  92. Liu X.W. Sun Y.T. Research progress on clinical and pharmacological effects of Papaverine. Zhongguo Yaowu Yu Linchuang 2006 6 09 697 699 10.3969/j.issn.1671‑2560.2006.09.019
    [Google Scholar]
  93. Wang Y. Fan X.X. Yang J. Wang Z.Q. Wang N. Chen J.Q. Liu C.X. Ma X.J. Gao X.L. Tu P.F. Chai X.Y. [Research progress on terpenes and pharmacological effects of Saussurea lappa]. Zhongguo Zhongyao Zazhi 2020 45 24 5917 5928 10.19540/j.cnki.cjcmm.20200903.601 33496131
    [Google Scholar]
  94. Qu Y. Fu C.M. Hu H.L. Zhang J.M. Xu L.J. Effects of Radix vladimiriae and paper-roast products on gastric empty andintestinal propulsive function of mice. Huaxi Yaoxue Zazhi 2010 25 03 269 271 10.13375/j.cnki.wcjps.2010.03.006
    [Google Scholar]
  95. He K. Hu Y. Ma H. Zou Z. Xiao Y. Yang Y. Feng M. Li X. Ye X. Rhizoma Coptidis alkaloids alleviate hyperlipidemia in B6 mice by modulating gut microbiota and bile acid pathways. Biochim. Biophys. Acta Mol. Basis Dis. 2016 1862 9 1696 1709 10.1016/j.bbadis.2016.06.006 27287254
    [Google Scholar]
  96. Zhang X. Zhao Y. Xu J. Xue Z. Zhang M. Pang X. Zhang X. Zhao L. Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats. Sci. Rep. 2015 5 1 14405 10.1038/srep14405 26396057
    [Google Scholar]
  97. Yu L.Y. Li X. Cai P.J. Qiang M.Q. Dong B.H. Jiang Y.X. Huang Q.W. Chen Z.M. Effects of Zingiber officinale and processed Zingiber officinale on pharmacodynamic indexes and intestinal flora on gastric ulcer rats with spleen-stomach deficiency and cold type. China Pharm. 2022 33 20 2460 2465 10.6039/j.issn.1001‑0408.2022.20.06
    [Google Scholar]
  98. Fu M. Study on Chemical Constituents of Coptis Chinensis and Dried Ginger Herb Combination and its Anti-gastric Cancer Effect, Hubei Univ. Chin. Med. 2023 10.27134/d.cnki.ghbzc.2022.000102
    [Google Scholar]
  99. Li W. Hua B. Saud S.M. Lin H. Hou W. Matter M.S. Jia L. Colburn N.H. Young M.R. Berberine regulates AMP‐activated protein kinase signaling pathways and inhibits colon tumorigenesis in mice. Mol. Carcinog. 2015 54 10 1096 1109 10.1002/mc.22179 24838344
    [Google Scholar]
  100. Achiwa Y. Hasegawa K. Udagawa Y. Regulation of the phosphatidylinositol 3-kinase-Akt and the mitogen-activated protein kinase pathways by ursolic acid in human endometrial cancer cells. Biosci. Biotechnol. Biochem. 2007 71 1 31 37 10.1271/bbb.60288 17213663
    [Google Scholar]
  101. Lei P. Li Z. Hua Q. Song P. Gao L. Zhou L. Cai Q. Ursolic acid alleviates neuroinflammation after intracerebral hemorrhage by mediating microglial pyroptosis via the NF-κB/NLRP3/GSDMD Pathway. Int. J. Mol. Sci. 2023 24 19 14771 10.3390/ijms241914771 37834220
    [Google Scholar]
  102. Zhang S.X. Li J.L. Feng W.J. Effects of berberine and Wnt/β-catenin signaling pathway inhibitors onproliferation, apoptosis and glucose metabolism of gastric cancer cell line MKN45. J. Basic Clin. Med. 2020 26 07 893 897
    [Google Scholar]
  103. Liu S. Wang J.W. Anti-colorectal Cancer Mechanism of Zuojinwan and lts Main Monomer Components: A Review. Zhongguo Shiyan Fangjixue Zazhi 2023 29 22 204 214 10.13422/j.cnki.syfjx.20232225
    [Google Scholar]
  104. Huang H. Kim M.O. Kim K.R. Anticancer effects of 6-shogaol via the AKT signaling pathway in oral squamous cell carcinoma. J. Appl. Oral Sci. 2021
    [Google Scholar]
  105. Qi L.W. Zhang Z. Zhang C.F. Anderson S. Liu Q. Yuan C.S. Wang C.Z. Anti-colon cancer effects of 6-shogaol through G2/M cell cycle arrest by p53/p21-cdc2/cdc25A crosstalk. Am. J. Chin. Med. 2015 43 4 743 756 10.1142/S0192415X15500469 26119958
    [Google Scholar]
  106. Xu L. Lu X. Li T. Dai R.Z. Jiang Y. Effects of dehydrocostus lactone on proliferation,metastasis and invasion of laryngeal carcinoma cells via PI3K/Akt pathway. J. Med. Res. 2023 52 09 108 112 10.11969/j.issn.1673‑548X.2023.09.022
    [Google Scholar]
  107. Shao Y.P. Liu B. Li W.M. Shao X.L. Chen Q.G. Dehydrocostus lactone induces autophagy,apoptosis,and oxidative stress in gastric cancer cells. Chin. J. Comp. Med. 2021 31 12 27 34 10.3969/j.issn.1671‑7856.2021.12.005
    [Google Scholar]
  108. Miao J.W. Chen J. Deng X.S. Xiong S. Li G.L. Ma Q. Dehydrocostuslactone inhibits proliferation and promotes apoptosis of human hepatocellular carcinoma cell line HepG2. Basic Clin. Med. 2020 40 10 1369 1373 10.16352/j.issn.1001‑6325.2020.10.011
    [Google Scholar]
  109. Lu Q. Tang Y. Luo S. Gong Q. Li C. Coptisine, the Characteristic Constituent from Coptis chinensis, Exhibits Significant Therapeutic Potential in Treating Cancers, Metabolic and Inflammatory Diseases. Am. J. Chin. Med. 2023 51 8 2121 2156 10.1142/S0192415X2350091X 37930333
    [Google Scholar]
  110. Kong W. Wei J. Abidi P. Lin M. Inaba S. Li C. Wang Y. Wang Z. Si S. Pan H. Wang S. Wu J. Wang Y. Li Z. Liu J. Jiang J.D. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat. Med. 2004 10 12 1344 1351 10.1038/nm1135 15531889
    [Google Scholar]
  111. Ynag X.Y. Huang M.Y. Shi Z.Y. Yan D. Study on hypoglycemic mechanism of berberine through glucose transporterexpression in intestinall cells. Zhonghua Zhongyiyao Zazhi 2021 36 04 1926 1930
    [Google Scholar]
  112. Yu H. Tang H. Hu G. Chen Z. Guo M. Jiang B. Zhang E. Hu C. Comparative study on main compounds and hypoglycemic effects of dispensing granules of Coptidis Rhizoma and Scutellaria–Coptis herb couple with traditional decoction. Chin. Med. 2023 18 1 141 141 10.1186/s13020‑023‑00848‑z 37907988
    [Google Scholar]
  113. Chen Z.X. Wang C.X. Xu L.Q. Liu Y.Y. Effect of Berberine on gastrointestinal hormones and glucose and lipid metabolismin patients with early type 2 diabetes mellitus. China Mod. Med. 2021 28 34 120-122 126 https://kns.cnki.net/kcms2/article/abstract?v=FY8FZShUIjFSQn7PP1BLxNQfHB34l9BPa95JnoBqskm5dcHy0D7J5zLsnTJoTVPjQdHXZGTTeEXqOgxuGt7T-MxwduFkf2jSfKFJPagEMVqyL5Z1_eBBlyZpAC1LN8IKKko_7vkpSkocxW4KPWPVHg==&uniplatform=NZKPT&language=CHS
    [Google Scholar]
  114. Wang L. Zhang H.Y. Wang L. [Comparison of pharmacological effects of Fructus Mume and its processed products]. Zhong Yao Cai 2010 33 3 353 356 10.13863/j.issn1001‑4454.2010.03.01 20681297
    [Google Scholar]
  115. Xu L. Fan Q.L. Advances in the molecular mechanisms of ursolic acid and its isomer oleanolic acic on treatment of type 2 diabetes and assciated complications. Chin. J. New Clinical Med. 2019 12 07 702 707 10.3969/j.issn.1674‑3806.2019.07.02
    [Google Scholar]
  116. Xiao W.P. Yang F.F. Wu H.Z. Xiong Y.Y. Predicting the Mechanism of the Analgesic Property of Yanhusuo Based on Network Pharmacology. Nat. Prod. Commun. 2019 14 10 10.1177/1934578X19883071
    [Google Scholar]
  117. Wang L. Zhang Y. Wang Z. Gong N. Kweon T.D. Vo B. Wang C. Zhang X. Chung J.Y. Alachkar A. Liang X. Luo D.Z. Civelli O. The antinociceptive properties of the Corydalis yanhusu extract. PLoS One 2016 11 9 e0162875 10.1371/journal.pone.0162875 27622550
    [Google Scholar]
  118. Wang Z.C. Jiang M.R. Yue Z.Z. Zhang J.Q. Chen M.Y. Wang H.N. Wei X.T. Wang M.L. Shi S.H. Wang Y.Z. Safety and analgesic effect of total alkaloids of Corydalis yanhusuo patch on neuropathic pain rats. Mod. J. Integrated Trad. Chin. and Western Med. 2023 32 03 336 341 10.3969/j.issn.1008‑8849.2023.03.008
  119. Guo J. Ding N. Chen X.X. Therapeutic Effect of Papaverine Hydrochloride in Acute Calculus-caused Renal Colic Unresponsive to Conventional Treatment. Chin. Gen. Pract. 2011 14 18 2043 2045 10.3969/j.issn.1007‑9572.2011.18.017
    [Google Scholar]
  120. Yang K. Li Z.Z. Pan L. Zhang J. Wei W.S. Zhao Q.M. Xu Z.Y. Gao B.R. Protective effects of total fumaric alkaloids on myocardium of rats with isoproterenol-induced myocardial infarction. Chin. J. Clin. Res 2016 29 08 1057 1061 10.13429/j.cnki.cjcr.2016.08.013
    [Google Scholar]
  121. Gao Z.X. Wang X.Q. Zhou G.S. Wang T.S. Yu B. Yan H. Research Progress on Processing Methods, Chemical Constituents, Pharmacologica Action, and Prediction Analysis of Quality Markers of Black Ginger. J. Nanjing Univ. Tradit. Chin. Med. 2023 39 09 927 942 10.14148/j.issn.1672‑0482.2023.0927
    [Google Scholar]
  122. Tang Y. Su H. Nie K. Wang H. Gao Y. Chen S. Lu F. Dong H. Berberine exerts antidepressant effects in vivo and in vitro through the PI3K/AKT/CREB/BDNF signaling pathway. Biomed. Pharmacother. 2024 170 116012 10.1016/j.biopha.2023.116012 38113631
    [Google Scholar]
  123. Zeng L.Y. Zeng H.L. Tan S.Y. Yan G.Y. Huang T.Y. Zhang L.W. Guo J.M. Mao L.N. Overview of Study on Production Mechanism,Metabolism,Biological Activity of 5-HMF and Its Changes in Chinese Medicine Processing. J. Basic Clin. Med. 2023 29 03 507 514 10.19945/j.cnki.issn.1006‑3250.2023.03.022
    [Google Scholar]
  124. Yan S.G. Hui Y. Li Q. Li J.T. Wei H.L. Effect of Coptidis Rhizoma-Zingiberis Rhizoma Extract on Colonic Epithelium TLR4/NF-kB Signaling Pathway in Mice with Ulcerative Colitis. Zhongguo Shiyan Fangjixue Zazhi 2020 26 04 70 75 10.13422/j.cnki.syfjx.20200202
    [Google Scholar]
  125. Zhang W.J. Ning H.C. Zhou Y. Liu L. Zhao Y. Effect of Compatibility of Coptidis and Ginger on Pharmacokinetics of Five Alkaloids ofcoptidis in Rats. Acta Chin. Med.Pharmacol 2015 43 04 15 19 10.19664/j.cnki.1002‑2392.2015.04.006
    [Google Scholar]
  126. Huang W.J. Liu J. Chen L. Effects of different proportions compatibility of Coptis chinensis Franch.and Zingiber officinale Roscoe on the content of effective components. Xinjiang Yike Daxue Xuebao 2018 41 10 1298 1301 10.3969/j.issn.1009‑5551.2018.10.025
    [Google Scholar]
  127. Yu C.L. Lu Y.J. Wu Q.F. Optimization of anti-influenza effect compatibility ratio of Huanglian(CoptidisRhizoma)-Ganjiang(Zingiberis Rhizoma) via response surface method. Chin, Archives Tradit. Chin. Med. 2020 38 4 98 100 10.13193/j.issn.1673‑7717.2020.04.023
    [Google Scholar]
  128. Wen J.X. Li Y. Hao J.J. Study on the Mechanism of Coptidis Rhizoma-Aucklandiae Radix on the Treatment of Ulcerative Colitis Based on Network Pharmacology. J. Dali Univ. 2019 4 10 32 39 10.3969/j.issn.2096‑2266.2019.10.008
    [Google Scholar]
  129. Wan L.L. Zhang Z.Q. Wang Y.Z. Chen Y.Q. Optimum selection of the compatibility ratio of Coptidis Rhizoma and Aucklandiae Radix in Xianglian pills. Zhong Yao Cai 2008 31 12 1898 1900 10.13863/j.issn1001‑4454.2008.12.044
    [Google Scholar]
  130. Wan L.L. Zhang Z.Q. Liu W.J. Liu Z.H. Pharmacokinetic Study on Berberine in the Extractof Rhizoma Coptidis-RadixAucklandiae Drug-pair in Rats. Chin. J. Mod. Appl. Pharm. 2009 26 06 443 446 10.13748/j.cnki.issn1007‑7693.2009.06.005
    [Google Scholar]
  131. Yang Y.T. Qian C.C. Wu R. Wang R. Ou H.M. Liu S.J. Exploring the mechanism of the Fructus Mume and Rhizoma Coptidis herb pair intervention in Ulcerative Colitis from the perspective of inflammation and immunity based on systemic pharmacology. BMC Complement Med Ther. 2023 23 1 11 10.1186/s12906‑022‑03823‑7
    [Google Scholar]
  132. Shi Y.H. Fan H.S. Liu X. Xiao P. Shen W.X. H.B. Chen HB and D.D. Sun. The Study of Compatibility Mechanism of Coptidis Rhizoma-Mume Fructus in Xiaoai Jiedu Prescription from Perspective of Chemical Components and Intestinal Microflora. J. Nanjing Univ. Tradit. Chin. Med. 2019 35 02 199 204 10.14148/j.issn.1672‑0482.2019.0199
    [Google Scholar]
  133. Jiang X. Li S.S. Zhang B. Liu L. Weng L.D. Liu Q. Studies on Fingerprint of Coptis -Prunus Mum Couplet Medicines of Different Proportions. Liaoning Zhongyiyao Daxue Xuebao 2012 14 10 195 197 10.13194/j.jlunivtcm.2012.10.197.jiangx.052
    [Google Scholar]
  134. Chen H. Zhou J. Xu H.L. Zhou L. Effect and Mechanism of COPTIDIS RHIZOMA and MUME FRUCTUS Extracts on LPS-Induced Inflammation in Mice. Pharmacol. Clin. Chin. Mater. Med. 2023 39 05 46 51 10.13412/j.cnki.zyyl.20230420.007
    [Google Scholar]
  135. The Pharmacopoeia Committee Pharmacopoeia of the People’s Republic of China 2020 Edition. 2020 https://db2.ouryao.com/yd2020/index.php?cid=1
    [Google Scholar]
  136. Chen Y. Gao C.X. Ye C.S. Zhang Y.J. Jiang X.Y. Quan S.J. The chemical constituents of Wumei pills were identified by UHPLC-Q-Orbitrap HRMS. Zhong Yao Cai 2022 45 09 2151 2156 10.13863/j.issn1001‑4454.2022.09.022
    [Google Scholar]
  137. Tang W.R. Tian M.G. Tang L. Du H. Fan G. Pan Z. Study on 1H-NMR Fingerprints of Prunus mume. China Pharm 2018 29 19 2644 2647 10.6039/j.issn.1001‑0408.2018.19.12
    [Google Scholar]
  138. Wang X.H. Liu L. Wang J. Jin Y. Study on quality standard of Guchang Zhixie pills. Shaanxi J. Tradit. Chin. Med 2014 35 09 1244 1247 10.3969/j.issn.1000‑7369.2014.09.079
    [Google Scholar]
  139. Liu Y.R. Song Z.X. Zhang Y.L. Ye N. Cai M.M. Wang X.H. Tang Z.S. Liu L. SQFM Methods Based on HPLC-DAD with Five Wavelengths for Fingerprint Determination of Guchang Zhixie Pill and Powders. Zhongguo Shiyan Fangjixue Zazhi 2015 21 15 65 70 10.13422/j.cnki.syfjx.2015150065
    [Google Scholar]
  140. Wang M. Shi Y.J. Liu L. Wang X.H. Nian J.J. Wu J.H. Study on mixing uniformity of Guchang Zhixie Pills by near infrared spectroscopy. Shaanxi J. Tradit. Chin. Med. 2016 37 01 109 110 10.3969/j.issn.1000‑7369.2016.01.056
    [Google Scholar]
  141. Liu Y.L. Yuan H. Li D.M. Feng L. The contents of three alkaloids in Papaveris Pericarpium were determined by UPLC method. Zhong Yao Cai 2011 34 09 1386 1388 10.13863/j.issn1001‑4454.2011.09.028
    [Google Scholar]
  142. Li D. Li J.T. Zeng Y. Zhang H.C. Xiao H. Wang J.Y. Study on the content of effective components in different grades of Papaveris Pericarpium. Zhongguo Zhongyao Zazhi 2010 35 17 2246 2249 https://doi.org/CNKI:SUN:ZGZY.0.2010-17-005 21137333
    [Google Scholar]
  143. Ji S. Wang K. Determination of morphine, codeine and papaverine in poppy husk by GC. Chin. Tradit. Herb. Drugs. 1998 8 526 528
    [Google Scholar]
  144. Wang W.F. Wei W.G. Determination of morphine and berberine hydrochloride in Guchang Zhixie Pills by HPLC. Chin. Trad. Patent Med. 2010 32 06 967 970 https://doi.org/CNKI:SUN:ZCYA.0.2010-06-028
    [Google Scholar]
  145. Oka P. Parr H. Barberio B. Black C.J. Savarino E.V. Ford A.C. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 2020 5 10 908 917 10.1016/S2468‑1253(20)30217‑X
    [Google Scholar]
/content/journals/ctmc/10.2174/0115680266328765250217050926
Loading
Guchang Zhixie Pill: A Comprehensive Review of the Clinical Applications, Toxicological Profile, and Quality Markers
Bentham Science Publishers ; https://doi.org/10.2174/0115680266328765250217050926
/content/journals/ctmc/10.2174/0115680266328765250217050926
/content/journals/ctmc/10.2174/0115680266328765250217050926
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: quality markers ; historical development ; TOXICOLOGY ; clinical applications ; Guchang Zhixie Pill

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test